Examkin

Question

Difficulty: Very hardPediatric Cardiovascular Disorders

An 8-month-old infant with an unrepaired congenital heart defect presents to the emergency department with an acute episode of extreme irritability, tachypnea, and profound cyanosis. The parents report the episode began shortly after a prolonged crying spell. On physical examination, the infant's oxygen saturation is 56% on room air, and a previously noted harsh, systolic ejection murmur at the left upper sternal border is now remarkably diminished. The medical team determines the patient is experiencing a severe, progressive hypercyanotic ('tet') spell.

Arrange the following therapeutic interventions in the correct sequential order for managing this acute presentation, progressing from immediate initial measures to pharmacological therapies for a refractory episode.

  1. 1Initiate a physical maneuver to acutely increase systemic vascular resistance
  2. 2Administer a non-pharmacologic agent that acts as a pulmonary vasodilator
  3. 3Administer an opioid analgesic to depress the respiratory center and blunt sympathetic tone
  4. 4Administer a rapid volume expansion with isotonic crystalloid
  5. 5Initiate a continuous infusion of a selective alpha-1 adrenergic receptor agonist

Answer

The correct sequence is: 1) Initiate a physical maneuver (knee-chest position), 2) Administer a non-pharmacologic pulmonary vasodilator (oxygen), 3) Administer an opioid analgesic (morphine), 4) Administer rapid volume expansion (IV fluids), 5) Initiate an alpha-1 agonist infusion (phenylephrine).
The management of a hypercyanotic spell follows a logical sequence aimed at reversing the pathophysiologic mismatch between pulmonary and systemic resistance. Knee-chest positioning instantly increases SVR by compressing the femoral arteries. Oxygen acts as a pulmonary vasodilator to decrease PVR. Morphine interrupts the cycle of agitation, hyperpnea, and catecholamine-induced infundibular spasm. An isotonic fluid bolus then increases RV preload to improve pulmonary flow. Finally, if the spell is refractory, phenylephrine provides robust alpha-1 mediated vasoconstriction to forcefully elevate SVR above RVOT resistance.

Step-by-Step Solution

1
Identify the clinical presentation and underlying pathophysiology.
The infant is experiencing a hypercyanotic ('tet') spell due to Tetralogy of Fallot.
Extreme cyanosis, irritability, and a diminished systolic murmur (indicating severely reduced flow across the right ventricular outflow tract) after crying are classic hallmarks.
2
Prioritize immediate, non-invasive physical interventions.
Place the infant in the knee-chest position.
This is the fastest intervention, requiring no equipment, and mechanically increases systemic vascular resistance (SVR) to reverse the right-to-left shunt.
3
Add immediate non-invasive respiratory support.
Apply 100% supplemental oxygen.
Oxygen decreases pulmonary vascular resistance (PVR), encouraging blood flow to the lungs, and should be given concurrently with or immediately after positioning.
4
Determine the first-line pharmacological intervention to address the trigger.
Administer morphine.
Morphine suppresses the respiratory center to stop hyperpnea and blunts the sympathetic surge causing infundibular spasm. It is often administered prior to painful IV access attempts to avoid worsening the spell.
5
Address hemodynamics via volume status once vascular access is established.
Give an IV fluid bolus.
Volume expansion increases right ventricular preload, which provides the necessary driving pressure to push blood past the fixed or dynamic RVOT obstruction.
6
Select the appropriate advanced vasoactive agent for refractory cases.
Infuse phenylephrine.
When standard measures fail, a pure alpha-1 agonist forcefully raises SVR to a level higher than the RVOT resistance, forcing blood into the pulmonary bed.

Key Concept

Sequential management of hypercyanotic (tet) spells prioritizes interventions that increase systemic vascular resistance, decrease pulmonary vascular resistance, and relieve dynamic right ventricular outflow tract obstruction.
Rate this question

Topics

Pediatric Cardiovascular Disorders

More questions from this topic